Browse by category

A research team affiliated with National Institute of Standards and Technology has made a significant discovery explaining why liver cancers associated with obesity and metabolic disorders tend to be more aggressive and less responsive to conventional treatments. The study reveals that a specific signalling pathway involving endotrophin - a protein secreted during liver fibrosis - and the receptor protein CD44 promotes tumour malignancy and drug resistance. Led by Professor J